These 6 Coronavirus Vaccine Candidates Are The Likeliest To Succeed, Says Morgan Stanley
With about eight coronavirus vaccine candidates in clinical trials and 110 more in clinical testing, the race to a commercial product is intensifying. Against this backdrop, an analyst at Morgan Stanley looked at the most promising programs.